plus500


Pink Sheets

Insys Therapeutics, Inc., formerly Neopharm Inc., is a specialty pharmaceutical company that develops and focuses to commercialize pharmaceutical products that target the unmet needs of cancer patients, with an initial focus on cancer-supportive care. The Company has assembled a product pipeline targeting cancer-supportive care and cancer therapy. The Company’s supportive care product candidates include Subsys, a fast-acting sublingual fentanyl spray for the treatment of breakthrough cancer pain (BTCP), and its family of dronabinol product candidates for the treatment of chemotherapy-induced nausea and vomiting (CINV), and appetite stimulation in acquired immune deficiency syndrome (AIDS) patients. Subsys and its generic Dronabinol SG Capsule product candidates are both under review for marketing approval by the United Staes Food and Drug Administration (FDA). The Company is also developing cancer therapeutics, which is LEP-ETU. 

http://www.insysrx.com
Address
10220 South 51st Street Suite 2
Phoenix, AZ 85044-5231
United States 
+1-602-9102617 (Phone)
 
 
 
 

 

Copyright  2011  Ernstrade.com